INS and Insulin resistance: T1DM is a chronic, immune-mediated disease characterized by the destruction of insulin-producing β-cells in the pancreas (Norris et al., 2020), while T2DM is primarily characterized by insulin resistance and impaired insulin secretion (DeFronzo et al., 2015).